UNSPSC 51285907: Methenamine mandelate

This classification denotes a urinary anti-infective agent with the molecular formula C8H8O3.C6H12N4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 695N30CINR, chemically known as 1,3,5,7-tetraazatricyclo(3.3.1.1(3,7))decane, mono(alpha-hydroxybenzeneacetate) but more generally known as methenamine mandelate, which bears US NIH Compound Identifier 11478. European Medicines Agency schedules Methenamine mandelate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03216MIG.

SMILES: OC(C1CCCCC1)C(=O)O.N12CN3CN(CN(C3)C2)C1.

UNSPSC 51285907 Methenamine mandelate is a Commodity code nominally naming a single urinary antiseptic compound, but recent state and local solicitations tagged with this code show little alignment with that specific pharmaceutical. Instead, the code appears in procurement records for broader medical and pharmaceutical supply categories — naloxone and drug deactivation systems, generic multi-source pharmaceuticals and OTC products, medical and first aid supplies for emergency response, and pharmacy benefit program administration. State and local health departments, city fire departments, and cooperative purchasing alliances are the primary issuing bodies, spanning from county health operations to multi-state consortia. The scope of work under the code encompasses procurement of emergency medications, generic pharmaceutical manufacturing contracts, and medical consumables for public health and rescue operations rather than the compound the code nominally describes.

Recent activity concentrates in Florida, Minnesota, and Texas. Seminole County, Florida issued IFB 60459723LAS seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries due by July 26, 2023. The City of Tampa posted ITB 26P00145 for medical and first aid supplies (169 line items) for the Tampa Fire Department Rescue Division with a March 13, 2026 deadline and an estimated contract value of $700,000, designated as a sheltered market for certified Small Local Business Enterprises with a 5% bid discount up to $10,000. The Minnesota Department of Administration, on behalf of the Minnesota Multistate Cooperative Purchasing Alliance, issued RFP S1070000015802 for generic multi-source pharmaceuticals and OTC products with a March 26, 2026 deadline, serving multiple state and local participants including Oregon. The Texas Health and Human Services Commission posted Request for Information HHS0017013 on April 3, 2026 to explore vendor capabilities for direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager arrangements. The code's recent activity reflects significant mismatch between its nominal pharmaceutical designation and the actual scope of medical procurement being conducted.